Nextrials, a California technology firm, announced a long-term deal with Novacea. The drug company will rely on Nextrials’ Prism application (which includes electronic data capture, inventory management, and drug safety features) for a Phase III trial of a prostate cancer drug. In a news release, Novacea praised the 100 percent uptime of Nextrials’ system.